0001415889-18-000158.txt : 20180131
0001415889-18-000158.hdr.sgml : 20180131
20180131175617
ACCESSION NUMBER: 0001415889-18-000158
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180129
FILED AS OF DATE: 20180131
DATE AS OF CHANGE: 20180131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baity Glenn
CENTRAL INDEX KEY: 0001487100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 18564010
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
form4-01312018_020102.xml
X0306
4
2018-01-29
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001487100
Baity Glenn
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
false
true
false
false
EVP AND GC
Common Stock
2018-01-29
4
S
0
36558
32.3884
D
83734
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2017 and amended in November 2017.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.37 to $32.45 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
/s/ Glenn F. Baity
2018-01-31